# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-026973
Filing Date
2023-08-07
Accepted
2023-08-07 09:30:27
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 906301
2 |  | ex31-1.htm | EX-31.1 | 11373
3 |  | ex31-2.htm | EX-31.2 | 11114
4 |  | ex32-1.htm | EX-32.1 | 4113
5 |  | ex32-2.htm | EX-32.2 | 3973
| Complete submission text file | 0001493152-23-026973.txt |  | 4985713

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | gtbp-20230630.xsd | EX-101.SCH | 38522
7 | XBRL CALCULATION FILE | gtbp-20230630_cal.xml | EX-101.CAL | 40081
8 | XBRL DEFINITION FILE | gtbp-20230630_def.xml | EX-101.DEF | 172507
9 | XBRL LABEL FILE | gtbp-20230630_lab.xml | EX-101.LAB | 327196
10 | XBRL PRESENTATION FILE | gtbp-20230630_pre.xml | EX-101.PRE | 266093
53 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 741372

Mailing Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005
Business Address 8000 MARINA BLVD SUITE 100 BRISBANE CA 94005 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

EIN.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40023 | Film No.: 231145910
SIC: 2834 Pharmaceutical Preparations